181 related articles for article (PubMed ID: 37052841)
1. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
Yang R; Zhang GGZ; Zemlyanov DY; Purohit HS; Taylor LS
Pharm Res; 2023 Dec; 40(12):2817-2845. PubMed ID: 37052841
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
[TBL] [Abstract][Full Text] [Related]
3. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
4. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Pharm Res; 2022 Feb; 39(2):381-397. PubMed ID: 35169959
[TBL] [Abstract][Full Text] [Related]
5. Release Mechanisms of Amorphous Solid Dispersions: Role of Drug-Polymer Phase Separation and Morphology.
Yang R; Zhang GGZ; Zemlyanov DY; Purohit HS; Taylor LS
J Pharm Sci; 2023 Jan; 112(1):304-317. PubMed ID: 36306863
[TBL] [Abstract][Full Text] [Related]
6. Phase separation in surfactant-containing amorphous solid dispersions: Orthogonal analytical methods to probe the effects of surfactants on morphology and phase composition.
Yang R; Zhang GGZ; Kjoller K; Dillon E; Purohit HS; Taylor LS
Int J Pharm; 2022 May; 619():121708. PubMed ID: 35364219
[TBL] [Abstract][Full Text] [Related]
7. Role of surfactants in improving release from higher drug loading amorphous solid dispersions.
Correa-Soto CE; Gao Y; Indulkar AS; Zhang GGZ; Taylor LS
Int J Pharm; 2022 Sep; 625():122120. PubMed ID: 35987321
[TBL] [Abstract][Full Text] [Related]
8. Direct Visualization of Drug-Polymer Phase Separation in Ritonavir-Copovidone Amorphous Solid Dispersions Using
Shi C; Li L; Zhang GGZ; Borchardt TB
Mol Pharm; 2019 Nov; 16(11):4751-4754. PubMed ID: 31553871
[TBL] [Abstract][Full Text] [Related]
9. Formulation and Processing Strategies which Underpin Susceptibility to Matrix Crystallization in Amorphous Solid Dispersions.
Moseson DE; Hiew TN; Su Y; Taylor LS
J Pharm Sci; 2023 Jan; 112(1):108-122. PubMed ID: 35367246
[TBL] [Abstract][Full Text] [Related]
10. Aqueous Dissolution and Dispersion Behavior of Polyvinylpyrrolidone Vinyl Acetate-based Amorphous Solid Dispersion of Ritonavir Prepared by Hot-Melt Extrusion with and without Added Surfactants.
Siriwannakij N; Heimbach T; Serajuddin ATM
J Pharm Sci; 2021 Apr; 110(4):1480-1494. PubMed ID: 32827493
[TBL] [Abstract][Full Text] [Related]
11. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
Yang R; Mann AKP; Van Duong T; Ormes JD; Okoh GA; Hermans A; Taylor LS
Mol Pharm; 2021 May; 18(5):2066-2081. PubMed ID: 33784104
[TBL] [Abstract][Full Text] [Related]
12. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
[TBL] [Abstract][Full Text] [Related]
13. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
14. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
Saboo S; Kestur US; Flaherty DP; Taylor LS
Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
[TBL] [Abstract][Full Text] [Related]
15. Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions.
Hiew TN; Zemlyanov DY; Taylor LS
Mol Pharm; 2022 Feb; 19(2):392-413. PubMed ID: 34494842
[TBL] [Abstract][Full Text] [Related]
16. Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.
Li N; Cape JL; Mankani BR; Zemlyanov DY; Shepard KB; Morgen MM; Taylor LS
Mol Pharm; 2020 Oct; 17(10):4004-4017. PubMed ID: 32931293
[TBL] [Abstract][Full Text] [Related]
17. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
18. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
Moseson DE; Corum ID; Lust A; Altman KJ; Hiew TN; Eren A; Nagy ZK; Taylor LS
AAPS J; 2021 May; 23(4):69. PubMed ID: 34002256
[TBL] [Abstract][Full Text] [Related]
19. Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.
Correa Soto CE; Gao Y; Indulkar AS; Ueda K; Zhang GGZ; Taylor LS
Pharm Res; 2022 Jan; 39(1):167-188. PubMed ID: 35013849
[TBL] [Abstract][Full Text] [Related]
20. Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers.
Saboo S; Moseson DE; Kestur US; Taylor LS
Eur J Pharm Sci; 2020 Dec; 155():105514. PubMed ID: 32810579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
